“…In a recently completed double-blind placebo-controlled study, there was a tendency towards less abdominal pain and discomfort in patients suffering from functional bowel disorders after oxytocin administration [24]. The analgetic effect has been ascribed to central effects as it is exerted by intracerebroventricular injection, and by peripheral administration in 1,000-fold higher doses [25]. Oxytocin is assumed to activate secondary mechanisms, as oxytocin receptor antagonists are unable to reverse the effects, while the opioid receptor antagonist naloxone does [25].…”